Page 2 - Show Efficacy News Today : Breaking News, Live Updates & Top Stories | Vimarsana

CoVIg-19 Plasma Alliance Saturday, April 3, 2021 2:00PM IST (8:30AM GMT)   Osaka, Japan & King of Prussia, Pa., United States:    Phase 3 Inpatient Treatment With Anti-Coronavirus Immunoglobulin (ITAC) Clinical Trial Sponsored and Funded by the National Institute of Allergy and Infectious Diseases (NIAID), Part of the National Institutes of Health (NIH), Did Not Meet Its Endpoints to Show Efficacy in Adults Hospitalized With COVID-19 The CoVIg-19 Plasma Alliance today announced that the Phase 3 Inpatient Treatment with Anti-Corona...

Women? >> it's a huge problem. it is the most prevalent sexual problem for women across all ages. we estimate about 10% of all women have hypoactive sexual desire disorder. >> so there is never a drug like this approved by the fda for women. so when arousal is psychological as we're learning, what can they do? >> well, you know, that's onest reasons why viagra and those kinds of drugs are approved because for men, the problem has been arousal. but for women, desire is relatively complicated. and there's a psychological component and there's a biological component. and so what this drug was doi...